|
HPV Clinical Trial Results
Second HPV Vaccine Shows Early Positive Results
(Posted: 07/17/2007) - The vaccine Cervarix® was 90 percent effective against two types of human papillomavirus (HPV) that can cause cervical cancer, according to the June 30, 2007, Lancet.
New Data from HPV Vaccine Trials Available
(Posted: 05/22/2007) - Results from three years of follow-up data from two clinical trials of Gardasil, a vaccine that protects against the HPV viruses known to cause 70 percent of all cases of cervical cancer, have been published in the May 10, 2007, New England Journal of Medicine.
Vaccine Against Cervical Cancer Virus is Effective for More than Four Years
(Posted: 04/19/2006) - An experimental vaccine that protects against two types of a virus that can cause cervical cancer remained highly effective for up to 4.5 years and caused very few adverse effects, according to the April 15, 2006, issue of the Lancet.
Vaccine May Help Reduce Risk of Cervical Cancer
(Posted: 05/11/2005) - An experimental vaccine prevented young women from becoming persistently infected with two types of a virus that, together, cause more than two-thirds of all cases of cervical cancer, according to the May 2005 issue of The Lancet Oncology.
Vaccine Protects Against Virus Linked to Half of All Cervical Cancers
(Posted: 11/26/2002) - An experimental vaccine prevented women from becoming persistently infected with a virus that is associated with half of all cervical cancers, researchers reported in the Nov. 21, 2002, issue of the New England Journal of Medicine.
HPV Testing Shows Which Pap Abnormalities Need Attention
(Posted: 02/20/2001) - Results from the ALTS trial, reported in the Feb. 21, 2001, issue of the Journal of the National Cancer Institute.
< Previous Section | Next Section > |
